News Release 

Blocking dopamine weakens effects of cocaine

If extended to humans, findings suggest treatment route for drug addiction, relapse

Society for Neuroscience


IMAGE: Blocking dopamine receptors decreases seeking and taking behavior. view more 

Credit: Kim et al., eNeuro 2019

Blocking dopamine receptors in different regions of the amygdala reduces drug seeking and taking behavior with varying longevity, according to research in rats published in eNeuro.

The amygdala contains receptors for dopamine, a neurotransmitter involved in reward seeking, and has been shown to influence cocaine reward behaviors, making it a target for addiction treatment research.

Matthew Lattal and Earnest Kim at Oregon Health & Science University blocked dopamine receptors in the amygdala of rats that were self-administering cocaine. The rats were trained to push a lever that caused another lever to appear, which modeled drug-seeking behavior, and to press the second lever to receive a dose of cocaine, which was the actual drug-taking behavior.

Blocking dopamine receptors in the basolateral amygdala gradually decreased drug seeking and taking behaviors, even when the rats were placed in a new environment. In the central amygdala, blocking dopamine caused a rapid decrease in drug seeking and taking. The effect was reversed when the rats entered a new environment.

These findings clarify the unique roles of the basolateral and central amygdala and reveal that blocking dopamine during cocaine use weakens the effects of the drug. This offers insight into potential therapies for drug addiction and relapse.


Manuscript title: Context-Dependent and -Independent Effects of D1 Receptor Antagonism in the Basolateral and Central Amygdala During Cocaine Self-Administration

Please contact for full-text PDF and to join SfN's journals media list.

About eNeuro

eNeuro, the Society for Neuroscience's open-access journal launched in 2014, publishes rigorous neuroscience research with double-blind peer review that masks the identity of both the authors and reviewers, minimizing the potential for implicit biases. eNeuro is distinguished by a broader scope and balanced perspective achieved by publishing negative results, failure to replicate or replication studies. New research, computational neuroscience, theories and methods are also published.

About The Society for Neuroscience

The Society for Neuroscience is the world's largest organization of scientists and physicians devoted to understanding the brain and nervous system. The nonprofit organization, founded in 1969, now has nearly 37,000 members in more than 90 countries and over 130 chapters worldwide.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.